Copyright
©The Author(s) 2025.
World J Gastroenterol. Mar 7, 2025; 31(9): 100271
Published online Mar 7, 2025. doi: 10.3748/wjg.v31.i9.100271
Published online Mar 7, 2025. doi: 10.3748/wjg.v31.i9.100271
Table 1 Scoring criteria for inflammation-associated histological changes
Score | Inflammation | Crypt damage | Ulceration | Edema |
0 | No infiltrate | None | None | Absent |
1 | Occasional cells limited to submucosa | Some crypt damage, spaces between crypts | Small, focal ulcers | Present |
2 | Significant presence of inflammatory cells in submucosa limited to focal areas | Larger spaces between crypts, loss of goblet cells, some shortening of crypts | Frequent small ulcers | - |
3 | Infiltrate is present in both submucosa and lamina propria, limited to focal areas | Large areas without crypts, surrounded by normal crypts | Large areas lacking surface epithelium | - |
4 | A large amount of infiltrate in the submucosa, lamina propria, and surrounding blood vessels, covering large areas of mucosa | No crypts | - | - |
5 | Transmural inflammation (mucosa to muscularis) | - | - | - |
- Citation: Qin Y, Zhang RY, Zhang Y, Zhao YQ, Hao HF, Wang JP. Network pharmacology and in vivo study: Unraveling the therapeutic mechanisms of Panax ginseng in potentially treating ulcerative colitis. World J Gastroenterol 2025; 31(9): 100271
- URL: https://www.wjgnet.com/1007-9327/full/v31/i9/100271.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i9.100271